DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Nanoparticles - Metal & Metal Oxides Market In Healthcare By Type (Gold, Silver, Iron Oxide, Alumina, Gadolinium, Cerium), By Application (In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro assays), & Segment Forecasts, 2013 - 2025" report to their offering.
The global nanoparticles - metal & metal oxides market in healthcare is anticipated to reach USD 80.74 billion by 2025
Several nanotechnologies based medicines have been put forward for approval by the FDA which is anticipated to propel growth.
Success of nanomedicine has prompted the development of enhanced nanomaterials for clinical applications with particular emphasis in therapy and diagnostics. This has resulted into the significant production of metal oxide particles that hold potential utility in human medicine.
Remarkable evolution has been made in nanoparticle based medicines for theranostic applications in disease management. Diverse metals have been used for development of medicines with a promise to optimize the efficacy of nanomedicines and to improve the current standard of medical and clinical practices.
These particles are recognized to have major applications in drug delivery, diagnostic products, biomarker discovery, and product packaging. Widespread application spectrum of these particles in maintaining human health is expected to dramatically impact the progress of this market in the coming years.
Moreover, metal oxides are observed to have significant role in cancer treatment. Nanoparticle-augmented systems enable high-concentration targeted drug delivery to cancer cells, which in turn, is expected to enhance the usage rate of metal nanoparticles for cancer treatment. Development of drug delivery strategies using nanoparticle approaches are expected to bring about changes effective for cancer treatment.
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Nanoparticles - Metal & Metal Oxides Market Variables, Trends& Scope
4 Nanoparticles - Metal & Metal Oxides: Type Estimates & Trend Analysis
5 Nanoparticles - Metal & Metal Oxides: Application Estimates & Trend Analysis
6 Nanoparticles - Metal & Metal Oxides: Regional Estimates & Trend Analysis, by Type& Application
7 Competitive Landscape
- Immunolight LLC
- Merck KGaA
- Sigma-Aldrich CoLLC
- CYTIMMUNE SCIENCES, INC.
- CELGENE CORPORATION
- Abraxis BioScience, Inc.
- Brigham and Women's Hospital (BWH)
- Nanoprobes, Inc.
- Nanospectra Biosciences, Inc.
- Nanoplex Technologies, Inc.
- Pfizer Inc.
- BIND Therapeutics
For more information about this report visit http://www.researchandmarkets.com/research/zwf4c3/nanoparticles